Schlunk, Frieder http://orcid.org/0000-0002-1268-0627
Kuthe, Johannes
Harmel, Peter
Audebert, Heinrich
Hanning, Uta
Bohner, Georg
Scheel, Michael
Kleine, Justus
Nawabi, Jawed
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 23 February 2021
Accepted: 9 January 2022
First Online: 15 January 2022
Declarations
:
: The retrospective study was approved by the responsible ethics committee (Ethik-Komission der Charité Berlin; Identification Number EA4/011/20). Informed consent of individual patients was waived for this retrospective study with anonymized data according to pertinent institutional guidelines.
: Not applicable.
: Heinrich Audebert reports funding from the German Research Foundation (DFG), the federal Ministry of Education and Research (BMBF), Berlin Innovation Funds, Pfizer and German Stroke Foundation. He reports speaker fees and consultancy honoraria during the conduct of the study from Bayer Vital, Boehringer Ingelheim Pharma, Bristol-Myers Squibb, Novo Nordisk, Pfizer, and Takeda.